Walleye Capital’s 60 Degrees Pharmaceuticals Warrant SXTPW Stock Holding History

Walleye Capital’s Portfolio SXTPW Stock Details SXTPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10K	Sell	200,481 -799	-0.4%	-$51	﹤0.01%	4161
2025 Q4	$12.6K	Sell	201,280 -21,626	-10%	-$1.06K	﹤0.01%	4286
2025 Q3	$8.25K	Hold	222,906	–	–	﹤0.01%	4289
2025 Q2	$12.6K	Hold	222,906	–	–	﹤0.01%	4285
2025 Q1	$5.13K	Hold	222,906	–	–	﹤0.01%	4102
2024 Q4	$6.62K	Hold	222,906	–	–	﹤0.01%	4607
2024 Q3	$12.8K	Hold	222,906	–	–	﹤0.01%	4884
2024 Q2	$15.6K	Hold	222,906	–	–	﹤0.01%	5160
2024 Q1	$16.9K	Hold	222,906	–	–	﹤0.01%	4969
2023 Q4	$11.1K	Hold	222,906	–	–	﹤0.01%	4550
2023 Q3	$78K	Buy	+222,906	New	+$95.7K	﹤0.01%	4041

Other funds holding SXTPW

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Torno Capital Cohasset, Massachusetts $725M AUM 62.71% 1-Year Est. Return

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Walleye Capital's SXTPW Position: Q1 2026 in Review

Walleye Capital reduced its 60 Degrees Pharmaceuticals Warrant (SXTPW) stake by 0.4% in Q1 2026, selling an estimated $51 and leaving 200,481 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #4161.

Walleye Capital first reported a position in SXTPW in Q3 2023 and has held it in 11 quarters since. The position peaked at $78K in Q3 2023. 8 funds tracked by Wall St. Rank hold SXTPW as of Q1 2026.

Walleye Capital held 200,481 shares of 60 Degrees Pharmaceuticals Warrant worth $10K as of Q1 2026.
Walleye Capital sold 799 60 Degrees Pharmaceuticals Warrant shares in Q1 2026, an estimated $51.
60 Degrees Pharmaceuticals Warrant made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #4161 holding.
Walleye Capital first reported a position in 60 Degrees Pharmaceuticals Warrant in Q3 2023 and has held it in 11 quarters since.
Walleye Capital's 60 Degrees Pharmaceuticals Warrant position peaked at $78K in Q3 2023.
8 funds tracked by Wall St. Rank held 60 Degrees Pharmaceuticals Warrant as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.